Stocks and Investing Stocks and Investing
Tue, August 2, 2016
Mon, August 1, 2016
Fri, July 29, 2016
Thu, July 28, 2016
Wed, July 27, 2016
Tue, July 26, 2016
Mon, July 25, 2016
Fri, July 22, 2016
Thu, July 21, 2016

Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $385 on, Jul 21st, 2016


Published on 2024-10-25 17:38:37 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $383 to $385 on, Jul 21st, 2016.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Aaron Gal of "Bernstein" Initiated at Buy on, Wednesday, June 29th, 2016